Somany Ceramics maintained their guidance of mid to high-single digit growth and expect margins to improve with better utilizations. Brand spends will continue to be ~2.5% of sales.
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Yes Securities Report
Subdued demand scenario keeps Somany Ceramics Ltd. performance under pressure. Company’s tiles revenue grew marginally by 3.5%YoY to Rs 5.46 billion wherein volumes increased by 4.5%YoY and realisations remained flattish over similar period. However, volume and revenue numbers were marginally better than our estimates.
Operating margins for the quarter stood at 8.3% versus estimate of 8.4% and as compared to 9.6%/8.4% margins in Q3 FY24/Q2 FY25 respectively. Lower volume off-take and reduction in average selling price weighed on operating margins.
Net profit de-grew sharply largely due to higher tax rates which as %PBT came in at 39% versus 31%/30% in Q3 FY24/Q2 FY25 respectively. Bathware biz revenue increased by 9%YoY to Rs 710 million.
Click on the attachment to read the full report:
Also Read: Kajaria Ceramics Q3 Results Review - Systematix Maintains 'Hold' On The Stock — Here's Why
DISCLAIMER
This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
RECOMMENDED FOR YOU

Fresh Version Of Income-Tax Bill Coming: What Taxpayers Can Expect


IndiGo Q1 Review — Muted Show; Forward-Looking Guidance Remains Intact, Says Motilal Oswal Maintaining 'Buy'


Rossari Biotech Q1 Results — HPPC, New Capacities To Drive Earnings Growth, Says DRChoksey Maintaining Buy


'Hold' Polycab Shares Maintains Nirmal Bang, Says Execution, Favorable Industry Tailwinds To Drive Growth
